国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Methylobacterium chloromethanicum 50S ribosomal protein L3 (rplC) CSB-YP486600MSY
CSB-EP486600MSY
CSB-BP486600MSY
CSB-MP486600MSY
CSB-EP486600MSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium chloromethanicum 30S ribosomal protein S17 (rpsQ) CSB-YP486601MSY
CSB-EP486601MSY
CSB-BP486601MSY
CSB-MP486601MSY
CSB-EP486601MSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium chloromethanicum 30S ribosomal protein S5 (rpsE) CSB-YP486602MSY
CSB-EP486602MSY
CSB-BP486602MSY
CSB-MP486602MSY
CSB-EP486602MSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium chloromethanicum Potassium-transporting ATPase A chain (kdpA), partial CSB-YP486603MSY
CSB-EP486603MSY
CSB-BP486603MSY
CSB-MP486603MSY
CSB-EP486603MSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium chloromethanicum Holo-[acyl-carrier-protein] synthase (acpS) CSB-YP486604MSY
CSB-EP486604MSY
CSB-BP486604MSY
CSB-MP486604MSY
CSB-EP486604MSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium chloromethanicum 30S ribosomal protein S6 (rpsF) CSB-YP486605MSY
CSB-EP486605MSY
CSB-BP486605MSY
CSB-MP486605MSY
CSB-EP486605MSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Probable HTH-type transcriptional regulator matA homolog (matA) CSB-YP486606ENM
CSB-EP486606ENM
CSB-BP486606ENM
CSB-MP486606ENM
CSB-EP486606ENM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Orotidine 5'-phosphate decarboxylase (pyrF) CSB-YP486607ENM
CSB-EP486607ENM
CSB-BP486607ENM
CSB-MP486607ENM
CSB-EP486607ENM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli 30S ribosomal protein S20 (rpsT) CSB-YP486608ENM
CSB-EP486608ENM
CSB-BP486608ENM
CSB-MP486608ENM
CSB-EP486608ENM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Probable crotonobetaine/carnitine-CoA ligase (caiC) CSB-YP486609ENM
CSB-EP486609ENM
CSB-BP486609ENM
CSB-MP486609ENM
CSB-EP486609ENM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Glutathione-regulated potassium-efflux system protein kefC (kefC), partial CSB-YP486610ENM
CSB-EP486610ENM
CSB-BP486610ENM
CSB-MP486610ENM
CSB-EP486610ENM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Ribulokinase (araB) CSB-YP486611ENM
CSB-EP486611ENM
CSB-BP486611ENM
CSB-MP486611ENM
CSB-EP486611ENM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli 50S ribosomal protein L14 (rplN) CSB-YP486612ENM
CSB-EP486612ENM
CSB-BP486612ENM
CSB-MP486612ENM
CSB-EP486612ENM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli 30S ribosomal protein S10 (rpsJ) CSB-YP486613ENM
CSB-EP486613ENM
CSB-BP486613ENM
CSB-MP486613ENM
CSB-EP486613ENM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Protein slyX (slyX) CSB-YP486614ENM
CSB-EP486614ENM
CSB-BP486614ENM
CSB-MP486614ENM
CSB-EP486614ENM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli 3-dehydroquinate synthase (aroB) CSB-YP486615ENM
CSB-EP486615ENM
CSB-BP486615ENM
CSB-MP486615ENM
CSB-EP486615ENM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Rhomboid protease glpG (glpG), partial CSB-YP486616ENM1
CSB-EP486616ENM1
CSB-BP486616ENM1
CSB-MP486616ENM1
CSB-EP486616ENM1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli 2,3-dihydroxyphenylpropionate/2,3-dihydroxicinnamic acid 1,2-dioxygenase (mhpB) CSB-YP486617ENM
CSB-EP486617ENM
CSB-BP486617ENM
CSB-MP486617ENM
CSB-EP486617ENM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli UPF0345 protein YaiE (yaiE) CSB-YP486618ENM
CSB-EP486618ENM
CSB-BP486618ENM
CSB-MP486618ENM
CSB-EP486618ENM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Voltage-gated ClC-type chloride channel ClcB (clcB), partial CSB-YP486619ENM
CSB-EP486619ENM
CSB-BP486619ENM
CSB-MP486619ENM
CSB-EP486619ENM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>